Literature DB >> 26757049

Volumetric Portal Embolization: A New Concept to Improve Liver Regeneration and Hepatocyte Engraftment.

Guillaume Pourcher1, Hoda El-Kehdy, Frederic Kanso, Marie-Therese Groyer-Picard, Martin Gaillard, Olivier Trassard, Istvan Blazsek, Hélène Agostini, Anne Dubart-Kupperschmitt, Ibrahim Dagher.   

Abstract

BACKGROUND: Hepatocyte transplantation has been proposed as an alternative to orthotopic liver transplantation to treat metabolic liver diseases. This approach requires preconditioning of the host liver to enhance engraftment of transplanted hepatocytes. Different methods are currently used in preclinical models: partial hepatectomy, portal ligature or embolization, and radiotherapy or chemotherapeutic drugs. However, these methods carry high risks of complications and are problematic for use in clinical practice. Here, we developed an innovative method called volumetric (distal, partial, and random) portal embolization (VPE), which preserves total liver volume.
METHODS: Embolization was performed in the portal trunk of C57BL6 adult mice with polyester microspheres, to ensure a bilateral and distal distribution. The repartition of microspheres was studied by angiographic and histological analyses. Liver regeneration was evaluated by Ki67 labeling. Optimal conditions for VPE were determined, and the resulting regeneration was compared with that after partial hepatectomy (70%). Labeled adult hepatocytes were then transplanted, and engraftment was compared between embolized (n = 19) and nonembolized mice (n = 8). Engraftment was assessed in vivo and histologically by tracking labeled cells at day 5.
RESULTS: The best volumetric embolization conditions, which resulted in the regeneration of 5% of total liver, were 8 × 10 ten-micron microspheres infused with a 29 G needle directly into the portal trunk at 3.3 μL/s. In these conditions, transplanted hepatocytes engraftment was significantly higher than that in control conditions (3 vs 0.65%).
CONCLUSIONS: The VPE is a new, minimally invasive, and efficient technique to prepare the host liver for cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26757049     DOI: 10.1097/TP.0000000000001024

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Regeneration and Cell Recruitment in an Improved Heterotopic Auxiliary Partial Liver Transplantation Model in the Rat.

Authors:  Yoshihiro Ono; Angelica Pérez-Gutiérrez; Mladen I Yovchev; Kentaro Matsubara; Shinichiro Yokota; Jorge Guzman-Lepe; Kan Handa; Alexandra Collin de l'Hortet; Angus W Thomson; David A Geller; Hiroshi Yagi; Michael Oertel; Alejandro Soto-Gutierrez
Journal:  Transplantation       Date:  2017-01       Impact factor: 4.939

2.  Clinical Hepatocyte Transplantation: What Is Next?

Authors:  James E Squires; Kyle A Soltys; Patrick McKiernan; Robert H Squires; Stephen C Strom; Ira J Fox; Alejandro Soto-Gutierrez
Journal:  Curr Transplant Rep       Date:  2017-10-14

Review 3.  Pluripotent-Stem-Cell-Derived Hepatic Cells: Hepatocytes and Organoids for Liver Therapy and Regeneration.

Authors:  Antonietta Messina; Eléanor Luce; Marwa Hussein; Anne Dubart-Kupperschmitt
Journal:  Cells       Date:  2020-02-12       Impact factor: 6.600

Review 4.  Stem cell therapy and tissue engineering strategies using cell aggregates and decellularized scaffolds for the rescue of liver failure.

Authors:  Jiabin Zhang; Hon Fai Chan; Haixia Wang; Dan Shao; Yu Tao; Mingqiang Li
Journal:  J Tissue Eng       Date:  2021-02-01       Impact factor: 7.813

5.  A Prospective Study of Liver Regeneration After Radiotherapy Based on a New (Su'S) Target Area Delineation.

Authors:  Ting-Shi Su; Li-Qing Li; Shi-Xiong Liang; Bang-De Xiang; Jian-Xu Li; Jia-Zhou Ye; Le-Qun Li
Journal:  Front Oncol       Date:  2021-08-26       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.